Skip to main content
Cardiolucent

Condition

Myocarditis

Recovery monitoring and long-term cardiac follow-up after heart muscle inflammation.

Myocarditis is inflammation of the heart muscle, most often triggered by a viral infection but also caused by certain medications, autoimmune conditions, or other infections. The clinical course is highly variable: many patients have a mild illness with full recovery, while a minority develop significant heart failure, arrhythmias, or sudden cardiac death. The acute phase often resembles a heart attack, with chest pain, troponin elevation, and EKG changes, but the coronary arteries are normal. After the acute illness, the focus shifts to monitoring ventricular function and identifying patients with persistent dysfunction or arrhythmias who need ongoing management. Dr. Kedan provides this longitudinal follow-up with serial imaging and individualized exercise guidance.

What Cardiolucent Evaluates

  • Detailed history of preceding illness, exposures, and timeline of symptoms
  • Echocardiography with strain imaging at baseline and over time
  • POCUS at every visit
  • EKG and rhythm monitoring for arrhythmias common after myocarditis
  • Cardiac MRI in coordination with Cedars-Sinai when more detailed tissue characterization is needed
  • Biomarker trends (troponin, NT-proBNP) through recovery
  • Activity and exercise restriction guidance, particularly for athletes

Common Symptoms

  • Chest pain or pressure, sometimes mimicking a heart attack
  • Shortness of breath or reduced exercise tolerance
  • Palpitations or new arrhythmias
  • Fatigue and malaise, often following a viral illness
  • Symptoms of acute heart failure in more severe cases
  • Rarely, syncope or sudden cardiac death

Risk Factors

  • Recent viral infection
  • Certain medications, including some chemotherapy and immune checkpoint inhibitors
  • Autoimmune or systemic inflammatory diseases
  • Other infections (bacterial, parasitic, fungal in select cases)
  • Younger age at presentation (relative to atherosclerotic disease)
  • Male sex slightly more affected

How Cardiolucent Approaches Treatment

Acute treatment is supportive and tailored to severity, with hospital-level care for patients with reduced ventricular function or arrhythmias. Standard heart failure medications — beta-blockers, ACE inhibitors or ARBs (or ARNI), SGLT2 inhibitors, and mineralocorticoid receptor antagonists — are added when systolic dysfunction is present. Exercise restriction is recommended during the acute and early recovery period, particularly for athletes, with gradual return guided by serial imaging. Most patients recover fully; those with persistent dysfunction need ongoing guideline-directed heart failure therapy and surveillance.

Common Questions

Frequently Asked Questions

What is myocarditis?
Myocarditis is inflammation of the heart muscle, most often triggered by a viral infection, though medications, autoimmune diseases, and other infections can also be responsible. The inflammation can transiently weaken the heart and trigger arrhythmias.
How is myocarditis diagnosed?
Diagnosis combines clinical history, EKG and biomarker changes (especially troponin), and imaging. Echocardiography assesses ventricular function. Cardiac MRI is highly useful, showing characteristic patterns of edema and scar that support the diagnosis without biopsy in most cases.
Is myocarditis the same as pericarditis?
No, though they sometimes overlap. Pericarditis is inflammation of the sac around the heart; myocarditis is inflammation of the heart muscle itself. When both are involved, the condition is called myopericarditis.
Can myocarditis be caused by COVID-19 or vaccines?
Yes — myocarditis has been described after COVID-19 infection and, less commonly, after mRNA vaccines, particularly in young males. The vaccine-associated cases have generally been mild and self-limited. Dr. Kedan reviews the clinical course and imaging when these histories are relevant.
How long do I need to avoid exercise?
Current expert consensus recommends restricting strenuous exercise — particularly competitive athletics — for approximately three to six months after acute myocarditis, with return guided by repeat imaging and clinical assessment. Lighter activity may resume sooner in milder cases. Dr. Kedan tailors guidance to your specific case.
Will my heart function recover?
Most patients recover normal heart function. A minority have persistent dysfunction that requires ongoing heart failure therapy. Serial echocardiography over the months after the acute illness documents recovery and guides decisions.
What is the risk of arrhythmias?
Arrhythmias can occur both during and after acute myocarditis, ranging from extra beats to ventricular tachycardia. Monitoring during the acute phase and rhythm assessment during recovery are part of routine care.
Will I need long-term medications?
Patients with persistent ventricular dysfunction benefit from long-term guideline-directed heart failure therapy. Those who recover fully may eventually be able to stop these medications, though decisions are individualized based on imaging trends.
Should my family be screened?
Most cases of myocarditis are not inherited, and family screening is not routinely indicated. When there is a family history of cardiomyopathy or sudden death, genetic evaluation may be appropriate.
How do I schedule a consultation?
Call (310) 304-5555 or use the contact form to schedule with Dr. Kedan at the Beverly Hills office. Cardiolucent does not bill Medicare or insurance; a detailed superbill is provided for any out-of-network reimbursement.

Recovering from myocarditis with structured follow-up.

Schedule a consultation with Dr. Kedan in Beverly Hills.

Medical Disclaimer

The information on this site is for general educational purposes only and is not medical advice, diagnosis, or treatment. Reading this site does not create a doctor–patient relationship. Always consult a qualified healthcare professional for personal guidance. If this is an emergency, call 911. Mentions of medications, devices, or procedures are informational and not endorsements. Full medical disclaimer.

Some listed indications involve investigational/off-label use. Learn more.